1. Home
  2. WOR vs RCUS Comparison

WOR vs RCUS Comparison

Compare WOR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$56.35

Market Cap

3.0B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$31.00

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
RCUS
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
WOR
RCUS
Price
$56.35
$31.00
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$59.50
$31.90
AVG Volume (30 Days)
230.7K
1.4M
Earning Date
03-24-2026
05-05-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
2.17
N/A
Revenue
$1,153,762,000.00
$247,000,000.00
Revenue This Year
$22.21
N/A
Revenue Next Year
$6.03
$45.62
P/E Ratio
$25.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.01
$7.92
52 Week High
$67.80
$31.44

Technical Indicators

Market Signals
Indicator
WOR
RCUS
Relative Strength Index (RSI) 41.86 73.95
Support Level $51.93 $19.78
Resistance Level $56.13 N/A
Average True Range (ATR) 1.90 1.63
MACD -0.49 0.77
Stochastic Oscillator 21.90 90.94

Price Performance

Historical Comparison
WOR
RCUS

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: